M

Active Director Director DIN 09387696
DIN 09387696 First appointment Nov 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Manamohan

Data last updated:

Manamohan is a Director at Jan Med India Pharma Private Limited (since 2021). The company operates in Chemicals. Jan Med India Pharma Private Limited reported revenue of ₹23.2 Lakh (FY 2025).

DIN 09387696
Primary Designation Director
Industry Chemicals
First Appointment 03 Nov 2021
Oldest Company Age 5 yrs
Largest company Jan Med India Pharma Private Limited · ₹23.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jan Med India Pharma Private Limited U33100TZ2021PTC037476
Director03 Nov 20212021₹23.2 Lakh (FY 2025)Active

Board colleagues of Manamohan

NameDINCompanyDesignation
Thangaraj Sheela09387695Jan Med India Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Jan Med India Pharma Private Limited
Premium access

Shareholding and investment profile for Manamohan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manamohan

Manamohan currently holds 1 directorship: Jan Med India Pharma Private Limited (Director, since 03 Nov 2021, revenue ₹23.2 Lakh (FY 2025)).

Manamohan was first appointed on 03 Nov 2021 as Director at Jan Med India Pharma Private Limited.

The current boards of Manamohan's companies include Thangaraj Sheela (Jan Med India Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available